Divestiture • Life Science

RoundTable Healthcare Management Acquires Bioniche Pharma Holdings

On February 1, 2006, private equity firm RoundTable Healthcare Management acquired life science company Bioniche Pharma Holdings from Telesta Therapeutics

Acquisition Context
  • This is RoundTable Healthcare Management’s 3rd transaction in the Life Science sector.
  • This is RoundTable Healthcare Management’s 9th transaction in the United States.
  • This is RoundTable Healthcare Management’s 2nd transaction in Illinois.
Investment Fate
  • Bioniche Pharma Holdings was sold to a publicly-traded strategic buyer in 2010 for 550M USD.

Explore All 789 Divestiture Life Science Deals - Search the Database Free


M&A Deal Summary

Date February 1, 2006
Target Bioniche Pharma Holdings
Sector Life Science
Buyer(s) RoundTable Healthcare Management
Sellers(s) Telesta Therapeutics
Deal Type Divestiture

Target Company

Bioniche Pharma Holdings

Lake Forest, Illinois, United States
Bioniche Pharma Holdings Ltd. is a developer and manufacturer of injectable pharmaceutical products serving a variety of niche markets, including analgesics/anesthetics, orthopedics, oncology, and urology.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

RoundTable Healthcare Management

Lake Forest, Illinois, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 2.9B USD
Size Large
Type Sector Focused
DESCRIPTION

RoundTable Healthcare Partners is a specialist private equity firm that targets equity and junior capital investments in the healthcare industry. Specific areas of interest include medical devices, medical products and disposables, specialty pharmaceuticals, medication delivery systems, specialty distribution, and outsourced healthcare services. RoundTable typically makes equity investments of approximately $5 to $50 million in platform companies with revenues ranging from $25 to $300 million. RoundTable will not invest in service-oriented provider segments (such as managed care companies, hospitals or nursing homes), internet or biotechnology companies, or start-up/venture situations. RoundTable was formed in 2001 and is based in Lake Forest, Illinois.


Deal Context for Buyer #
Overall 10 of 31
Sector: Life Science 3 of 3
Type: Divestiture 2 of 3
State: Illinois 2 of 2
Country: United States 9 of 30
Year: 2006 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-02-01 American Medical Instruments Holdings

Dartmouth, Massachusetts, United States

American Medical Instruments Holdings, Inc. is a specialty medical device manufacturer focused on three medical device markets: interventional diagnostics, ophthalmology, and wound closure.

Sell $785M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-09-06 Aspen Surgical

Caledonia, Michigan, United States

Aspen Surgical is a manufacturer and marketer of both OEM and branded disposable medical products for surgical and general healthcare applications. Aspen Surgical Product's major products included surgical needles, surgical skin markers, disposable light handles, instrument guards, anti-fog solutions, and surgical accessories. Aspen Surgical was founded in 1999 and is based in Caledonia, Michigan.

Buy -

Seller Profile 1

SELLER

Telesta Therapeutics

Saint-Laurent, Quebec, Canada

Category Company
Founded 1979
Sector Life Science
Employees202
DESCRIPTION

Telesta Therapeutics, Inc. is a clinical stage biotechnology company focused on the development, manufacturing, and commercialization of proprietary and innovative therapeutics for the global human health market. The Company’s anchor product is in Phase III clinical development to treat non-muscle-invasive bladder cancer.


Deal Context for Seller #
Overall 1 of 2
Sector: Life Science 1 of 1
Type: Divestiture 1 of 2
State: Illinois 1 of 1
Country: United States 1 of 1
Year: 2006 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-28 Bioniche s Animal Health Business - Bioniche Life Sciences

Belleville, Ontario, Canada

Sell CA$61M